Siemens Healthineers has reported early signs of stabilization in its diagnostics unit, according to analysts at Berenberg. This comes ahead of a planned carve-out for the division. As of now, operations in China are expected to hold steady, contributing about 7% of the unit’s total revenue, after a notable 30% decline over the past year.
In its fourth-quarter fiscal results for 2026, Siemens Healthineers revealed a decline in overall revenue and profitability. Despite these challenges, company executives reiterated their aim to achieve mid-teens profit margins in the midterm, Berenberg noted in their analysis. Following this news, Siemens Healthineers’ shares dropped by 0.4%.
The company continues to navigate a competitive market while addressing the issues impacting its diagnostics business.
